10561-89-4 Usage
Description
1-Methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid is a complex chemical compound that belongs to the dihydropyridine class. It features a carboxylic acid functional group and is widely recognized for its role as an intermediate in pharmaceutical drug synthesis.
Used in Pharmaceutical Industry:
1-Methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid is used as a key intermediate in the synthesis of calcium channel blockers, which are essential drugs for treating cardiovascular conditions such as hypertension, angina, and arrhythmias.
Used in Organic Synthesis:
1-Methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid serves as a versatile building block in organic synthesis, contributing to the development of a variety of bioactive molecules for different applications.
Used in Medicinal Chemistry:
Due to its structural properties, 1-Methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid is utilized in medicinal chemistry for the creation of new pharmaceutical agents with potential therapeutic benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 10561-89-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,5,6 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 10561-89:
(7*1)+(6*0)+(5*5)+(4*6)+(3*1)+(2*8)+(1*9)=84
84 % 10 = 4
So 10561-89-4 is a valid CAS Registry Number.
10561-89-4Relevant articles and documents
A new synthesis of 1-methyl-1,6-dihydro-6-oxonicotinic acid and 1-methyl-1,4-dihydro-4-oxonicotinic acid derivatives.
Tanaka,Price
, p. 2351 - 2352 (1967)
-
CHEMICAL MOLECULES THAT INHIBIT THE SLICING MECHANISM FOR TREATING DISEASES RESULTING FROM SPLICING ANOMALIES
-
, (2011/04/14)
The present invention relates to a compound of one of the formulas I to XXI; a pharmaceutical composition comprising at least one such compound; and the use of at least one such compound in preparing a drug to treat, in a subject, a genetic disease resulting from at least one splicing anomaly.
Heterocyclic mutilin esters and their use as antibacterials
-
, (2008/06/13)
Pleuromutilin compounds of the formula: 1are of use in anti-bacterial therapy.